Actovegin vs Cerebrolysin
Overview
Actovegin is primarily a pain management peptide, while Cerebrolysin is used for cognitive enhancement.
This page compares Actovegin and Cerebrolysin across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Actovegin | Cerebrolysin | |
|---|---|---|
| Category | Pain Management | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 5-10 ml | 5-10 ml |
| Frequency | multiple weekly | multiple times weekly |
| Reported benefits | Circulation-related pain relief, tissue oxygenation, healing support | Neuroprotection, stroke recovery support, cognitive improvement, neurodegenerative disease support |
| Reported side effects | Rare allergic reactions | Generally well-tolerated. Possible: dizziness, agitation |
Key differences
Primary use. Actovegin is categorised under Pain Management, while Cerebrolysin falls under Cognitive Enhancement. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Actovegin: not FDA-approved; treated as a research compound. Cerebrolysin: not FDA-approved; treated as a research compound.
Dosing. Actovegin is typically dosed at 5-10 ml (multiple weekly). Cerebrolysin is typically dosed at 5-10 ml (multiple times weekly).
Can you stack them?
Some protocols combine peptides, but stacking Actovegin and Cerebrolysin has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Actovegin and Cerebrolysin?
- Actovegin is primarily a pain management peptide, while Cerebrolysin is used for cognitive enhancement. Actovegin is not FDA-approved; generally classified as a research compound, whereas Cerebrolysin is not FDA-approved; generally classified as a research compound.
- What is Actovegin used for?
- Hypoxic pain and healing.
- What is Cerebrolysin used for?
- Neuroprotection, recovery.
- Can you take Actovegin and Cerebrolysin together?
- Some users combine peptides within a single protocol, but stacking Actovegin and Cerebrolysin has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Actovegin or Cerebrolysin FDA-approved?
- Actovegin is not FDA-approved; generally classified as a research compound. Cerebrolysin is not FDA-approved; generally classified as a research compound.
Read the full articles
- Actovegin — full monograph: mechanism, research, dosing & references
- Cerebrolysin — full monograph: mechanism, research, dosing & references